CERTARA INC. - COMMON STOCK

Certara Reports Third Quarter 2024 Financial Results

06 11 2024 16:15:01 提供 Nasdaq GlobeNewswire

Certara to Participate in the Stephens Annual Investment Conference

28 10 2024 16:15:00 提供 Nasdaq GlobeNewswire

Certara Appoints John Reynders as New Independent Board Member

16 10 2024 16:15:00 提供 Nasdaq GlobeNewswire

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

09 10 2024 16:15:00 提供 Nasdaq GlobeNewswire

Certara Completes Acquisition of Chemaxon

02 10 2024 16:15:00 提供 Nasdaq GlobeNewswire

Certara’s Simcyp Consortium Celebrates 25th Anniversary

24 9 2024 08:00:00 提供 Nasdaq GlobeNewswire

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

18 9 2024 08:00:00 提供 Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

21 8 2024 16:15:00 提供 Nasdaq GlobeNewswire

Certara Launches Phoenix™ Version 8.5 Drug Development Software

15 8 2024 16:15:00 提供 Nasdaq GlobeNewswire

Certara Reports Second Quarter 2024 Financial Results

06 8 2024 16:15:00 提供 Nasdaq GlobeNewswire

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

09 7 2024 16:45:00 提供 Nasdaq GlobeNewswire

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024

02 7 2024 16:15:00 提供 Nasdaq GlobeNewswire

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

17 6 2024 08:00:00 提供 Nasdaq GlobeNewswire

Certara to Participate in the Jefferies Global Healthcare Conference

29 5 2024 16:15:00 提供 Nasdaq GlobeNewswire

Certara Appoints New Chief Human Resources Officer & General Counsel

21 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Certara Reports First Quarter 2024 Financial Results

07 5 2024 16:15:00 提供 Nasdaq GlobeNewswire

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

16 4 2024 08:00:00 提供 Nasdaq GlobeNewswire

Certara Reports Fourth Quarter 2023 Financial Results

29 2 2024 16:10:01 提供 Nasdaq GlobeNewswire

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

01 2 2024 16:30:00 提供 Nasdaq GlobeNewswire

Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

13 12 2023 16:30:00 提供 Nasdaq GlobeNewswire